This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Chandra M. Kumar, MD
La Rabida Children's Hospital and Research Center Chicago

JAMA. 1979;241(16):1683-1684.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In his letter "Hereditary Angioedema" (240:2155, 1978), Dr Reimann does not mention the use of androgenic steroids for prophylaxis of attacks. Methyltestosterone was first effectively used by Spaulding¹ in 1960. This was followed by reports of effectiveness of less virilizing analogues, fluoxymesterone, oxymetholone,² and danazol.³ The latter is a synthetic androgen derivative with mild masculanizing effects⁴ and is currently the drug of choice for prophylactic management of hereditary angioedema.⁵ It is not only highly effective in preventing attacks but has been shown to raise Cl esterase inhibitor function, as well as its levels and that of C4, often to within normal range. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?